The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR-Mutant Non–Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors
2015 ◽
Vol 10
(6)
◽
pp. 903-909
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. e19078-e19078
2010 ◽
Vol 26
(2)
◽
pp. 424-431
◽